ES8304969A1 - Procedimiento para la obtencion de 2-aril-3,4-diazabiciclo 4.n.0-alq-2-en-5-onas. - Google Patents
Procedimiento para la obtencion de 2-aril-3,4-diazabiciclo 4.n.0-alq-2-en-5-onas.Info
- Publication number
- ES8304969A1 ES8304969A1 ES513391A ES513391A ES8304969A1 ES 8304969 A1 ES8304969 A1 ES 8304969A1 ES 513391 A ES513391 A ES 513391A ES 513391 A ES513391 A ES 513391A ES 8304969 A1 ES8304969 A1 ES 8304969A1
- Authority
- ES
- Spain
- Prior art keywords
- aryl
- ones
- compounds
- alken
- diaza
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
PROCEDIMIENTO PARA LA OBTENCION DE 2-ARIL-3,4-DIAZABICICLO 4.N.0 -ALQ-2-EN-5-ONAS, DE FORMULA (I), EN LAS QUE M Y N VALEN 1-3; Y R, R , R Y R SON HIDROGENO O ALQUILO C <- . CONSISTE EN LA REACCION DE UN ACIDO CICLOALCANOCARBOXILICO DE FORMULA (II) CON UNA HIDRACINA DE FORMULA NH NHR, EN LAS QUE R, R , R , R , M Y N TIENEN LOS MISMOS SIGNIFICADOS QUE EN LA FORMULA (I). LA REACCION DE CICLIZACION SE LLEVA A CABO EN UN DISOLVENTE INERTE, A UNA TEMPERATURA COMPRENDIDA ENTRE 40 C Y 150 C. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS PARA LA PROFILAXIS Y TERAPIA DE AFECCIONES TROMBOEMBOLICAS Y EN CASO DE HIPERTENSION.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19813124699 DE3124699A1 (de) | 1981-06-24 | 1981-06-24 | Neue 2-aryl-3,4-diaza-bicyclo(4.n.0.)alken-(2)-one-(5),verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8304969A1 true ES8304969A1 (es) | 1983-03-16 |
ES513391A0 ES513391A0 (es) | 1983-03-16 |
Family
ID=6135223
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES513391A Granted ES513391A0 (es) | 1981-06-24 | 1982-06-23 | Procedimiento para la obtencion de 2-aril-3,4-diazabiciclo 4.n.0-alq-2-en-5-onas. |
Country Status (16)
Country | Link |
---|---|
US (1) | US4474785A (es) |
EP (1) | EP0068310B1 (es) |
JP (1) | JPS58975A (es) |
AT (1) | ATE8891T1 (es) |
AU (1) | AU548396B2 (es) |
CA (1) | CA1171412A (es) |
CS (1) | CS227692B2 (es) |
DE (2) | DE3124699A1 (es) |
DK (1) | DK281482A (es) |
ES (1) | ES513391A0 (es) |
FI (1) | FI73425C (es) |
GR (1) | GR76010B (es) |
HU (1) | HU188179B (es) |
IL (1) | IL66009A (es) |
NO (1) | NO822102L (es) |
ZA (1) | ZA824438B (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4591591A (en) * | 1984-03-08 | 1986-05-27 | Eli Lilly And Company | Pyridazinone derivatives as inotropic agents |
US4647564A (en) * | 1984-05-14 | 1987-03-03 | Eli Lilly And Company | Inotropic agents |
ZA853440B (en) * | 1984-05-14 | 1986-12-30 | Lilly Co Eli | Indoline and 2-indolinone derivatives |
JPS6135240A (ja) * | 1984-07-27 | 1986-02-19 | 新東工業株式会社 | フルモ−ルド用発泡成形体 |
US4617302A (en) * | 1984-10-15 | 1986-10-14 | Eli Lilly And Company | Inotropic agents |
JPH0662608B2 (ja) * | 1985-08-26 | 1994-08-17 | 大塚製薬株式会社 | カルボスチリル誘導体 |
DE3535170A1 (de) * | 1985-10-02 | 1987-04-16 | Basf Ag | Verwendung von 2-aryl-3,4-diaza-bicyclo(4.n.0)alken-(2)-onen-(5) zur behandlung der herzinsuffizienz |
DE3535947A1 (de) * | 1985-10-09 | 1987-04-09 | Basf Ag | Kombinationspraeparat |
DE3535949A1 (de) * | 1985-10-09 | 1987-04-09 | Basf Ag | Kombinationspraeparat |
DE3631085A1 (de) * | 1986-09-12 | 1988-03-24 | Boehringer Mannheim Gmbh | Heterocyclisch substituierte indolinone, verfahren zu ihrer herstellung, arzneimittel sowie zwischenprodukte |
JPH02153730A (ja) * | 1988-10-24 | 1990-06-13 | Kanayama Kasei Kk | 断熱を要する機器の表面材 |
US5607863A (en) | 1991-05-29 | 1997-03-04 | Smithkline Diagnostics, Inc. | Barrier-controlled assay device |
US6168956B1 (en) | 1991-05-29 | 2001-01-02 | Beckman Coulter, Inc. | Multiple component chromatographic assay device |
US5869345A (en) | 1991-05-29 | 1999-02-09 | Smithkline Diagnostics, Inc. | Opposable-element assay device employing conductive barrier |
JP3442815B2 (ja) * | 1992-05-13 | 2003-09-02 | 第一製薬株式会社 | ジアザビシクロアルケン誘導体 |
SE9901825D0 (sv) | 1999-05-20 | 1999-05-20 | Amersham Pharm Biotech Ab | Foamed material filled with inner material |
SG11201406311UA (en) * | 2012-04-05 | 2014-11-27 | Chdi Foundation Inc | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
JP6449893B2 (ja) * | 2013-09-26 | 2019-01-09 | シーエイチディーアイ ファウンデーション,インコーポレーテッド | キヌレニン−3−モノオキシゲナーゼ阻害薬、医薬組成物、及びこれらの使用方法 |
JP2016536350A (ja) | 2013-09-26 | 2016-11-24 | シーエイチディーアイ ファウンデーション,インコーポレーテッド | キヌレニン−3−モノオキシゲナーゼ阻害薬、医薬組成物、及びこれらの使用方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH557820A (de) * | 1970-11-12 | 1975-01-15 | Sandoz Ag | Verfahren zur herstellung von neuen 2-(2-hydroxyalkyl)4,5-dihydro-pyridazin (2h)-3-onen. |
US3812256A (en) * | 1971-06-08 | 1974-05-21 | American Cyanamid Co | Novel method for lowering blood pressure in mammals |
US3746712A (en) * | 1971-06-08 | 1973-07-17 | A Ross | 6-(substituted-phenyl)-5-methyl-4,5-dihydro-3(2h)-pyridazinones |
US3888901A (en) * | 1972-07-20 | 1975-06-10 | American Cyanamid Co | Process of preparing 3-alkyl-3-(benzoyl)propionitriles |
US3824271A (en) * | 1972-07-20 | 1974-07-16 | American Cyanamid Co | 3-alkyl-3-(benzoyl)propionitriles |
DE2304977A1 (de) * | 1973-02-01 | 1974-08-08 | Basf Ag | Neue dihydropyridazinone |
US4070470A (en) * | 1974-06-24 | 1978-01-24 | Otsuka Pharmaceutical Co., Ltd. | Platelet aggregation inhibiting carbostyrils, their compositions and method of use |
DE2727481A1 (de) * | 1977-06-18 | 1979-01-11 | Basf Ag | Dihydropyridazone und dihydropyridazone enthaltende therapeutische mittel |
JPS54135785A (en) * | 1978-04-12 | 1979-10-22 | Yoshitomi Pharmaceut Ind Ltd | Pyridazinone derivative and its preparation |
DE2845220A1 (de) * | 1978-10-17 | 1980-04-30 | Yoshitomi Pharmaceutical | Pyridazinon-derivate, ihre salze mit saeuren, verfahren zu ihrer herstellung und ihre verwendung bei der behandlung von thrombosen und hypertonie |
US4258185A (en) * | 1978-10-17 | 1981-03-24 | Yoshitomi Pharmaceutical Industries, Ltd. | Pyridazinone compounds |
DE2845456A1 (de) * | 1978-10-19 | 1980-08-14 | Merck Patent Gmbh | 6-arylpyridazin-3-one und verfahren zu ihrer herstellung |
DE2854191A1 (de) * | 1978-12-15 | 1980-07-03 | Basf Ag | Dihydropyridazinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende therapeutische mittel |
DE2854475A1 (de) * | 1978-12-16 | 1980-07-03 | Basf Ag | Neue 3,4-diaza-bicyclo eckige klammer auf 4.1.0 eckige klammer zu hepten-(2)- one-(5), verfahren zu ihrer herstellung und diese verbindungen enthaltende therapeutische mittel |
-
1981
- 1981-06-24 DE DE19813124699 patent/DE3124699A1/de not_active Withdrawn
-
1982
- 1982-05-13 GR GR68151A patent/GR76010B/el unknown
- 1982-06-04 US US06/385,272 patent/US4474785A/en not_active Expired - Fee Related
- 1982-06-07 CA CA000404625A patent/CA1171412A/en not_active Expired
- 1982-06-08 IL IL66009A patent/IL66009A/xx unknown
- 1982-06-16 EP EP82105281A patent/EP0068310B1/de not_active Expired
- 1982-06-16 AT AT82105281T patent/ATE8891T1/de active
- 1982-06-16 DE DE8282105281T patent/DE3260540D1/de not_active Expired
- 1982-06-18 FI FI822203A patent/FI73425C/fi not_active IP Right Cessation
- 1982-06-23 JP JP57106986A patent/JPS58975A/ja active Pending
- 1982-06-23 ES ES513391A patent/ES513391A0/es active Granted
- 1982-06-23 ZA ZA824438A patent/ZA824438B/xx unknown
- 1982-06-23 AU AU85153/82A patent/AU548396B2/en not_active Ceased
- 1982-06-23 HU HU822034A patent/HU188179B/hu not_active IP Right Cessation
- 1982-06-23 NO NO822102A patent/NO822102L/no unknown
- 1982-06-23 DK DK281482A patent/DK281482A/da not_active Application Discontinuation
- 1982-06-24 CS CS824710A patent/CS227692B2/cs unknown
Also Published As
Publication number | Publication date |
---|---|
IL66009A (en) | 1986-02-28 |
HU188179B (en) | 1986-03-28 |
DE3260540D1 (en) | 1984-09-13 |
EP0068310A1 (de) | 1983-01-05 |
CA1171412A (en) | 1984-07-24 |
GR76010B (es) | 1984-08-03 |
FI822203L (fi) | 1982-12-25 |
FI73425B (fi) | 1987-06-30 |
DK281482A (da) | 1982-12-25 |
CS227692B2 (en) | 1984-05-14 |
FI822203A0 (fi) | 1982-06-18 |
ZA824438B (en) | 1983-05-25 |
AU8515382A (en) | 1983-01-13 |
NO822102L (no) | 1982-12-27 |
IL66009A0 (en) | 1982-09-30 |
ES513391A0 (es) | 1983-03-16 |
DE3124699A1 (de) | 1983-01-13 |
JPS58975A (ja) | 1983-01-06 |
EP0068310B1 (de) | 1984-08-08 |
ATE8891T1 (de) | 1984-08-15 |
FI73425C (fi) | 1987-10-09 |
US4474785A (en) | 1984-10-02 |
AU548396B2 (en) | 1985-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8304969A1 (es) | Procedimiento para la obtencion de 2-aril-3,4-diazabiciclo 4.n.0-alq-2-en-5-onas. | |
HUT50842A (en) | Process for producing new diphosphonic acid derivatives and pharmaceutical compositions comprising same | |
EP0110814A3 (en) | Beta-carbolines, process for their preparation and pharmaceutical compositions containing them | |
GR852979B (es) | ||
ES8607916A1 (es) | Un procedimiento para la preparacion de medicamentos influenciadores de la circulacion sanguinea, que contienen compuestos de bis (carboxamida) | |
EP0144991A3 (en) | Polymethosybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives | |
IL79910A0 (en) | Tricyclic compounds,process for the preparation thereof and pharmaceutical compositions containing the same | |
FR2370020A2 (fr) | Procede de preparation d'alkylphenols | |
ES8802612A1 (es) | Procedimiento para preparar derivados de benzisoselenazolilo | |
DE3277971D1 (en) | Acylamino-4-aza-1-adamantanes, process for their preparation and their therapeutic use | |
FR2446841A1 (fr) | Procede de preparation de 1a,3b-dihydroxy-d5-steroides | |
DE2960324D1 (en) | 4,5-methano-bufadienolide-rhamnosides, process for their preparation and medicines containing them | |
DE3463143D1 (en) | 1-0-alkyl-3-amino-propan-1.2-diol-2-0-phospholipids, process for producing the same and pharmaceutical preparations containing the same | |
ES8308562A1 (es) | Procedimiento para preparar 3',4',5'-trimetoxibenzoato de 1718-dehidorapovincaminol, util como agente activo en preparaciones farmaceuticas | |
DE3374401D1 (en) | 4-hydroxy-alpha-ethyl benzhydroles, process for their preparation and medicines containing these compounds | |
DE3264007D1 (en) | 5,6-dihydro-11-alkylene-morphantridin-6-ones, process for their preparation and pharmaceutical preparations containing them | |
FR2434142A1 (fr) | Procede de preparation d'amino-hydroxyanthraquinones | |
ES8502128A1 (es) | Procedimiento para la preparacion de derivados de 6 -metilprednisolona | |
DE3469358D1 (en) | Novel 3-(4'-aminobutylamino)-propylamino-bleomycin derivatives, a process for their preparation and their use as medicaments | |
GR850484B (es) | ||
DE3662892D1 (en) | Bisthiol phosphates, process for their preparation, their use as pesticides and agents therefor |